ArticleBMC infectious diseases2026
Sample pooling approaches simulated under resource scarcity, lapses in testing capacity, and rapid processing demands for surveillance testing: a data-driven performance comparison.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSample pooling is a critical strategy to meet increased testing demand and conserve resources in surveillance testing. Much of its effectiveness depends on how well optimized the pool size is to the prevalence of infection in the sampled population, which can be difficult to anticipate in many circumstances. Multiple methods exist to better optimize pooling, with unique trade-offs.
methodsPooling optimization methods were simulated to examine trade-offs between surveillance priorities and operational characteristics using SARS-CoV-2 surveillance data and workflows generated by the Virginia Tech Molecular Diagnostics Laboratory under varying capacity conditions. All in-house validation procedures were designed and established exclusively under CLIA to ensure full control of the analytical framework and to accurately reflect true capacity constraints. We used binary surveillance data to run Monte Carlo simulations (MCS) comparing conservative and large fixed pools, historical prevalence optimization (HPO), prevalence estimation testing (PET), truly optimized pooling, and individual testing. Median test counts from the MCS fed a discrete-event simulation (DES) that assessed processing time at different lab capacities under surveillance and outbreak conditions. We then used the combined performance results to build a classification tree to guide method selection under different testing priorities and constraints.
resultsMCS results indicated that small pools (4 samples), HPO, and PET resulted in test counts that were not statistically different from truly optimized pooling (p > 0.05). The DES showed that pooling methods generally performed comparably to individual testing in processing time at low laboratory capacity, but individual testing became faster as capacity increased. Across capacity conditions, individual testing processed fewer than 500 daily samples more quickly, yet it demanded more hands-on time than pooling. Large-scale surveillance favored pooled methods, which were quicker under most conditions, while outbreak scenarios often favored individual testing when capacity wasn’t highly limited. Machine learning analysis highlighted surveillance priorities and sample intake as key determinants in selecting the best pooling optimization method for the given circumstance.
conclusionThis study demonstrates the importance of maintaining multiple pooling optimization approaches and adapting strategies to match evolving demands and potential constraints in surveillance testing. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.